Neurodegeneration and -protection in Autoimmune CNS Inflammation
Overview
Authors
Affiliations
Neurodegeneration in multiple sclerosis (MS) is the structural correlate of permanent neurological disability in patients. The histopathological features of neurodegeneration include destruction of axons as well as apoptotic cell death of neuronal cell bodies. Therapeutic efforts to control these clinically important aspects of MS pathology showed limited success so far. In this review article, we give an overview about the current knowledge concerning the molecular mechanisms of neurodegeneration in autoimmune inflammation that is mainly derived from animal models. Further, we critically discuss experimental neuroprotective strategies with respect to their functional relevance and differentiate between anti-apoptotic and axon protective treatment approaches.
Shin T, Ahn M, Moon C, Kim S Anat Cell Biol. 2013; 45(4):215-20.
PMID: 23301189 PMC: 3531585. DOI: 10.5115/acb.2012.45.4.215.
Linker R, Lee D Exp Transl Stroke Med. 2010; 1:5.
PMID: 20142992 PMC: 2816864. DOI: 10.1186/2040-7378-1-5.
Hematopoietic cell activation in the subventricular zone after Theiler's virus infection.
Goings G, Greisman A, James R, Abram L, Begolka W, Miller S J Neuroinflammation. 2008; 5:44.
PMID: 18922161 PMC: 2577640. DOI: 10.1186/1742-2094-5-44.
Localized cell and drug delivery for auditory prostheses.
Hendricks J, Chikar J, Crumling M, Raphael Y, Martin D Hear Res. 2008; 242(1-2):117-31.
PMID: 18573323 PMC: 3073348. DOI: 10.1016/j.heares.2008.06.003.
Touil T, Ciric B, Ventura E, Shindler K, Gran B, Rostami A J Neurol Sci. 2008; 271(1-2):191-202.
PMID: 18544456 PMC: 2723951. DOI: 10.1016/j.jns.2008.04.030.